Can AbCellera Biologics (ABCL)’s Vertex Pharmaceuticals Incorporated (VRTX) Deal Turn its TCE Platform Into a Breakthrough?

This is a summary. Read the complete story at Yahoo Finance below.

Related Stories

marketsabout 2 hours ago

You might be shocked by how many stocks are in a bear market right now

The S&P 500 was trading within 2 percentage points of its record closing high on Tuesday, but dig a little bit deeper, and things are looking far less rosy.

MarketWatch

marketsabout 3 hours ago

Job openings are low and hiring is weak. Why the U.S. labor market won’t get better soon.

War, high gas prices, rising interest rates and AI are keeping a lid on U.S. job creation.

MarketWatch

marketsabout 3 hours ago

Medicare Advantage plans will be cheaper next year. Here’s the new cost.

Medicare beneficiaries can change their coverage during open enrollment, which begins Oct. 15.

MarketWatch